To find out more about the role of the complement system in viral infectious diseases, such as COVID-19, Select Science spoke with Dr. Marie-Agnès Dragon-Durey, associate professor in Immunology at the Université de Paris.
With over 20 years of experience improving diagnostics for autoimmune diseases and exploring the complement system, Dragon-Durey’s current research focuses on the use of biomarker assays to determine whether deficiencies, overactivation, or dysregulation in the complement system are causing or contributing to a person's disease or condition. Dragon-Durey has carried out work on the C4d protein using biomarker assays produced by Svar Life Science. We also have our own Calprotectin portfolio through our subsidiary Calpro.
We offer functional and biomarker assays that can be used to explore every angle of complement system-involvement in a wide range of application areas. > Learn more
Calpro is a world-leading provider of Calprotectin tests. Our aim is to provide solutions that are effective and user-friendly for the user, without compromising on the quality of the products. > Learn more